SPHK1 and breast carcinoma: Interestingly, Zhu et al. reported on longer PFS and OS in breast cancer patients with low expression of SPHK1 and a significant association of high SPHK1 expression with poor prognostic parameters (presence of lymph node metastasis, number of positive lymph nodes and presence of distant metastasis).